AKT1 and cancer: Eph forward signaling inhibits proliferation, survival, migration and invasion in several cancer types through regulation of oncogenic signaling pathways, including ERK, RAS/MAPK, PI3K-AKT, Abl-Crk [11, 13, 50, 61].